Article

Discussing Working After Cancer With Michele Longabaugh

What has been your experience with returning to work during and after cancer treatment? What would make the transition easier? Do you have advice to share with patients and survivors?

When I was diagnosed over six years ago with stage 4 anal cancer, I loved my job. Very quickly, my work and career took a back seat in my life. But ten months later there I was easing myself back into my job.

Today I work full time and am able to perform all my previous job duty requirements. I am by no means the working girl I once was, but with some adjustments and planning I am able to perform, and even enjoy again, the requirements my demanding career in Cardiac Rhythm Management as a device field representative.

Each survivor’s experience is unique in regard to desire and ability to return to work. Some survivors may have no ability or desire to return to work, while others financially may have no choice. Some employers, like mine, will allow individuals to ease back into work, while others may insist on enforcing disability leave policies.

One thing is for sure, with 1 in 3 people being diagnosed with cancer in their lifetime, it has a lasting impact on the workforce and the survivor’s career.

What has been your experience with returning to work during and after cancer treatment? What would make the transition easier? Do you have advice to share with patients and survivors?

Patients, survivors, nurses, and employers have a lot to share on these topics. Join us for our next #CureConnect tweet chat on Tuesday, August 9, at 9 p.m. EST to discuss these important topics. Don’t forget to include the #CureConnect hashtag in all of your responses! Read more here about the #CureConnect chat and how to participate.

Tweet: I’ll be at the #CureConnect chat Aug 9 at 9pm EST with @cure_magazine and @oncologynursingnews talking about working after cancer. Join me!

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Daniel Jernazian, who beat cancer twice, credits his sports mindset for survival and calls it winning his ‘life World Championship’.
Patients in rural or underserved areas may have worse outcomes, highlighting the need for early support to address care access barriers.
Image of man with text.
Image of doctor with text.
Dr. Emre Yekedüz discusses how ASCO 2025 highlights precision medicine, biomarkers and the gut microbiome as keys to advancing kidney cancer care.
Dr. Breelyn Wilky stresses the importance of expert guidance and second opinions for patients with GIST, as treatment options continue to evolve rapidly.
Mark Daniels, 83, credits CAR T-cell therapy and compassionate care for helping him overcome lymphoma and endure the isolating treatment toll.
An early study of BGB-16673 for hard-to-treat leukemia found that side effects were manageable with no new safety concerns.
Image of woman with text.
Image of goy, and text.
Related Content